Induction of Macrophage Chemotaxis by Aortic Extracts from Patients with Marfan Syndrome Is Related to Elastin Binding Protein

Gao Guo; Gehle, Petra; Doelken, Sandra; Martin-Ventura, José Luis; von Kodolitsch, Yskert; Hetzer, Roland; Robinson, Peter N.
May 2011
PLoS ONE;2011, Vol. 6 Issue 5, p1
Academic Journal
Marfan syndrome is an autosomal dominantly inherited disorder of connective tissue with prominent skeletal, ocular, and cardiovascular manifestations. Aortic aneurysm and dissection are the major determinants of premature death in untreated patients. In previous work, we showed that extracts of aortic tissues from the mgR mouse model of Marfan syndrome showed increased chemotactic stimulatory activity related to the elastin-binding protein. Aortic samples were collected from 6 patients with Marfan syndrome and 8 with isolated aneurysms of the ascending aorta. Control samples were obtained from 11 organ donors without known vascular or connective tissue diseases. Soluble proteins extracted from the aortic samples of the two patient groups were compared against buffer controls and against the aortic samples from controls with respect to the ability to induce macrophage chemotaxis as measured using a modified Boyden chamber, as well as the reactivity to a monoclonal antibody BA4 against bioactive elastin peptides using ELISA. Samples from Marfan patients displayed a statistically significant increase in chemotactic inductive activity compared to control samples. Additionally, reactivity to BA4 was significantly increased. Similar statistically significant increases were identified for the samples from patients with idiopathic thoracic aortic aneurysm. There was a significant correlation between the chemotactic index and BA4 reactivity, and the increases in chemotactic activity of extracts from Marfan patients could be inhibited by pretreatment with lactose, VGVAPG peptides, or BA4, which indicates the involvement of EBP in mediating the effects. Our results demonstrate that aortic extracts of patients with Marfan syndrome can elicit macrophage chemotaxis, similar to our previous study on aortic extracts of the mgR mouse model of Marfan syndrome (Guo et al., Circulation 2006; 114:1855-62).


Related Articles

  • Marfan syndrome linked to gene. Brown, Phyllidia // New Scientist;7/27/91, Vol. 131 Issue 1779, p20 

    Reports on U.S. researchers' identification of a gene linked with Marfan syndrome. Evidence confirming that the syndrome is caused by defects in fibrillin, a protein in connective tissue; Researchers' aim of discovering how fibrillin causes symptoms of the disease; Symptoms of Marfan syndrome.

  • The “Thumb Sign” in Marfan's Syndrome. Falk, Rodney H. // New England Journal of Medicine;8/17/95, Vol. 333 Issue 7, p430 

    The article presents an image of a medical patient displaying the symptoms of Marfan's Syndrome.

  • The Marfanoid Hypermobility Syndrome. Walker, Bryan A.; Beighton, Peter; Murdoch, J. Lamont // Annals of Internal Medicine;Aug69, Vol. 71 Issue 2, p349 

    Focuses on a patient who had the marfanoid habitus but no evidence of involvement of the aorta or dislocation of the lenses. Clinical features of the condition; Suggestion about the marfanoid hypermobility.

  • Marfan Syndrome: Identification And Management. Eaton, Leann; Meiner, Sue E. // MEDSURG Nursing;Apr99, Vol. 8 Issue 2, p113 

    Provides information on the identification and clinical management of the genetic disorder, Marfan's syndrome. Etiology; Pathogenesis; Clinical presentation of the syndrome.

  • Marfan's syndrome, Marfan syndrome.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1404 

    A definition of the term "Marfan's syndrome" or "Marfan syndrome" is presented, which refers to a hereditary degenerative disorder of connective tissue and bones, muscles, and ligaments caused by a mutation on chromosome 15 which affects about one in 5000-7500 persons .

  • MARFAN SYNDROME: The Silent Killer. Williams, Cheryl // USA Today Magazine;Nov89, Vol. 118 Issue 2534, p64 

    Focuses on the nature of the hereditary disorder called Marfan syndrome. Characteristics of the condition; Organs of the body affected by the condition; History of the discovery of the disease; Manifestations and symptoms of Marfan syndrome; Suspected cause of the condition; Tests that can be...

  • Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice. Van Herck, Jozef Leo; De Meyer, Guido R. Y.; Martinet, Wim; Bult, Hidde; Vrints, Christiaan J.; Herman, Arnold G. // Basic Research in Cardiology;Jan2010, Vol. 105 Issue 1, p39 

    The ubiquitin–proteasome system is involved in the development and progression of atherosclerosis. The aim of this study was to investigate whether plaque composition is affected by proteasome function. In vitro, the potent and selective proteasome inhibitor bortezomib induced apoptosis...

  • Reduced Activity of Serum β-Glucuronidase in Marfan Syndrome. Nakashima, Yasuhide // Angiology;Aug1986, Vol. 37 Issue 8, p576 

    Reduced activity of serum β-glucuronidase (EC was found in three patients with Marfan syndrome, two of whom were siblings. The serum β-glu-curonidase levels in the patients ranged from 294 to 439 μg (360.7± 73.2, mean±SD) of the released P-nitrophenol/100 ml of...

  • Aortic Root Repair for Thoracic Aorta False Aneurysm Following Bentall Procedure Kumar, Sanjay; Jones, Steve; Sivananthan, U.M.; McGoldrick, J.P. // Heart, Lung & Circulation;Aug2008, Vol. 17 Issue 4, p334 

    The Bentall procedure for aortic root replacement in Marfan''s syndrome is safe and durable. We describe successful repair of periprosthetic valvular leak, 12 years following Bentall repair with composite graft. The aim of this report is to analyse and evaluate technical factors leading to this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics